Serum total cholesterol and mortality in a Japanese population.

[1]  B. Johansson,et al.  The Kockum study: twenty-two-year follow-up. Coronary heart disease in a population in the south of Sweden. , 2009, Acta medica Scandinavica.

[2]  L. Carlson,et al.  Risk factors for death for males and females. A study of the death pattern in the Stockholm prospective study. , 2009, Acta medica Scandinavica.

[3]  S. Yusuf,et al.  Report of the Conference on Low Blood Cholesterol: Mortality Associations , 1992, Circulation.

[4]  D. Jacobs,et al.  Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial , 1992 .

[5]  D. Jacobs,et al.  Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.

[6]  A. Nissinen,et al.  Short- and long-term association of serum cholesterol with mortality. The 25-year follow-up of the Finnish cohorts of the seven countries study. , 1992, American journal of epidemiology.

[7]  J. Feldman,et al.  The low cholesterol-mortality association in a national cohort. , 1992, Journal of clinical epidemiology.

[8]  D. Reed,et al.  Will lowering population levels of serum cholesterol affect total mortality? Expectations from the Honolulu Heart Program. , 1992, Journal of clinical epidemiology.

[9]  J. Deschamps,et al.  Determinants of plasma retinol, beta-carotene, and alpha-tocopherol during adolescence. , 1991, The American journal of clinical nutrition.

[10]  V. Salomaa,et al.  Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. , 1991, JAMA.

[11]  I. Holme,et al.  An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. , 1990, Circulation.

[12]  K. Matthews,et al.  Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. , 1990, BMJ.

[13]  E. Barrett-Connor,et al.  Cancer mortality and lipid and lipoprotein levels. Lipid Research Clinics Program Mortality Follow-up Study. , 1990, American journal of epidemiology.

[14]  J. Carstensen,et al.  Cancer incidence and cancer mortality in relation to serum cholesterol. , 1989, Journal of the National Cancer Institute.

[15]  B. Angelin,et al.  HYPOCHOLESTEROLAEMIA AND INCREASED ELIMINATION OF LOW-DENSITY LIPOPROTEINS IN METASTATIC CANCER OF THE PROSTATE , 1989, The Lancet.

[16]  D. Reed,et al.  Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. , 1989, Stroke.

[17]  S. Pocock,et al.  Plasma cholesterol, coronary heart disease, and cancer , 1989, BMJ.

[18]  C. Isles,et al.  Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. , 1989, BMJ.

[19]  D. Jacobs,et al.  Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. , 1989, The New England journal of medicine.

[20]  D. Kromhout,et al.  Serum cholesterol and 25-year incidence of and mortality from myocardial infarction and cancer. The Zutphen Study. , 1988, Archives of internal medicine.

[21]  N. Wald,et al.  Plasma retinol, beta-carotene and vitamin E levels in relation to the future risk of breast cancer. , 1984, British Journal of Cancer.

[22]  A. Menotti,et al.  Coronary risk factors and survival probability from coronary and other causes of death. , 1987, American journal of epidemiology.

[23]  J. Cutler,et al.  Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. , 1987, JAMA.

[24]  J. Carstensen,et al.  Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. , 1986, The New England journal of medicine.

[25]  R. Brookmeyer,et al.  Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. , 1986, The New England journal of medicine.

[26]  H. Ginsberg,et al.  Hypocholesterolemia and acute myelogenous leukemia: Association between disease activity and plasma low‐density lipoprotein cholesterol concentrations , 1986, Cancer.

[27]  G. Gahrton,et al.  HYPOCHOLESTEROLAEMIA IN MALIGNANCY DUE TO ELEVATED LOW-DENSITY-LIPOPROTEIN-RECEPTOR ACTIVITY IN TUMOUR CELLS: EVIDENCE FROM STUDIES IN PATIENTS WITH LEUKAEMIA , 1985, The Lancet.

[28]  H. Blackburn,et al.  Serum cholesterol and cancer mortality in the Seven Countries Study. , 1985, American journal of epidemiology.

[29]  C. Salmond,et al.  Are low cholesterol values associated with excess mortality? , 1985, British medical journal.

[30]  N. Wald,et al.  Plasma retinol, beta-carotene and vitamin E levels in relation to the future risk of breast cancer. , 1984, British Journal of Cancer.

[31]  J. Salonen.  Risk of cancer and death in relation to serum cholesterol. A longitudinal study in an eastern Finnish population with high overall cholesterol level. , 1982, American journal of epidemiology.

[32]  A. Smith,et al.  Serum retinol and the inverse relationship between serum cholesterol and cancer. , 1982, British medical journal.

[33]  C. Date,et al.  Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. , 1982, Stroke.

[34]  T. Dawber,et al.  Serum cholesterol and mortality: the Yugoslavia Cardiovascular Disease Study. , 1981, American journal of epidemiology.

[35]  P. Sorlie,et al.  An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico. , 1981, American journal of epidemiology.

[36]  D. McGee,et al.  Serum cholesterol and mortality in a Japanese-American population: the Honolulu Heart program. , 1981, American journal of epidemiology.

[37]  U. Goldbourt,et al.  ASSOCIATIONS OF SERUM HIGH DENSITY LIPOPROTEIN AND TOTAL CHOLESTEROL WITH TOTAL, CARDIOVASCULAR, AND CANCER MORTALITY IN A 7-YEAR PROSPECTIVE STUDY OF 10 000 MEN , 1981, The Lancet.

[38]  H. Ueshima,et al.  Multivariate analysis of risk factors for stroke. Eight-year follow-up study of farming villages in Akita, Japan. , 1980, Preventive medicine.

[39]  F. Cambien,et al.  Total serum cholesterol and cancer mortality in a middle-aged male population. , 1980, American journal of epidemiology.

[40]  M. Shipley,et al.  PLASMA LIPIDS AND MORTALITY: A SOURCE OF ERROR , 1980, The Lancet.

[41]  J. Popper,et al.  Factors Related to Stroke Incidence in Hawaii Japanese Men: The Honolulu Heart Study , 1980, Stroke.

[42]  J. Ockene,et al.  Prevention of coronary heart disease. , 1976, British medical journal.

[43]  Plumley Pf.  Letter: the consultants' contract. , 1975, Lancet.

[44]  M. Iida,et al.  GEOGRAPHIC AND OCCUPATIONAL OF RISK FACTORS IN CARDIOVASCULAR DISEASES IN JAPAN , 1971 .

[45]  M. Marmot,et al.  Plasma cholesterol concentration and mortality. The Whitehall Study. , 1992, JAMA.

[46]  H. Stähelin,et al.  Beta-carotene and cancer prevention: the Basel Study. , 1991, The American journal of clinical nutrition.

[47]  R. Peto,et al.  Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. , 1988, American journal of epidemiology.

[48]  A. Reunanen,et al.  Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. , 1988, Journal of clinical epidemiology.

[49]  E. Barrett-Connor,et al.  Plasma cholesterol and cancer morbidity and mortality in an adult community. , 1984, Journal of chronic diseases.

[50]  A. Dyer,et al.  Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies. , 1981, Journal of chronic diseases.

[51]  C. Lamers,et al.  Letter: Streptozotocin in the Zollinger-Ellison syndrome. , 1975, Lancet.

[52]  A. Dietz,et al.  Relation of vitamin E and serum lipids. , 1969, Clinica chimica acta; international journal of clinical chemistry.